Tarsus Pharmaceuticals (TARS) Other Non Operating Income: 2021-2025
Historic Other Non Operating Income for Tarsus Pharmaceuticals (TARS) over the last 5 years, with Sep 2025 value amounting to $98,000.
- Tarsus Pharmaceuticals' Other Non Operating Income rose 46.27% to $98,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$61,000, marking a year-over-year increase of 96.71%. This contributed to the annual value of -$1.9 million for FY2024, which is 1761.54% down from last year.
- According to the latest figures from Q3 2025, Tarsus Pharmaceuticals' Other Non Operating Income is $98,000, which was up 167.59% from -$145,000 recorded in Q2 2025.
- In the past 5 years, Tarsus Pharmaceuticals' Other Non Operating Income ranged from a high of $235,000 in Q4 2021 and a low of -$1.9 million during Q2 2024.
- In the last 3 years, Tarsus Pharmaceuticals' Other Non Operating Income had a median value of -$47,500 in 2023 and averaged -$209,200.
- As far as peak fluctuations go, Tarsus Pharmaceuticals' Other Non Operating Income surged by 984.21% in 2023, and later plummeted by 4,036.17% in 2024.
- Tarsus Pharmaceuticals' Other Non Operating Income (Quarterly) stood at $235,000 in 2021, then plummeted by 91.91% to $19,000 in 2022, then spiked by 984.21% to $206,000 in 2023, then surged by 239.58% to $67,000 in 2024, then surged by 46.27% to $98,000 in 2025.
- Its last three reported values are $98,000 in Q3 2025, -$145,000 for Q2 2025, and -$81,000 during Q1 2025.